These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16284783)

  • 1. Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.
    Eltayb A; Wadenberg ML; Schilström B; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):195-202. PubMed ID: 16284783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat.
    Linnér L; Wiker C; Wadenberg ML; Schalling M; Svensson TH
    Neuropsychopharmacology; 2002 Nov; 27(5):691-8. PubMed ID: 12431844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML; Wiker C; Svensson TH
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.
    Marcus MM; Jardemark K; Malmerfelt A; Björkholm C; Svensson TH
    Neuropsychopharmacology; 2010 Aug; 35(9):1952-61. PubMed ID: 20463659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine.
    Jardemark KE; Konradsson A; Schilström B; Marcus MM; Svensson TH
    Synapse; 2009 Oct; 63(10):913-20. PubMed ID: 19582782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.
    Wiker C; Linnér L; Wadenberg ML; Svensson TH
    Neuropsychiatr Dis Treat; 2005 Sep; 1(3):253-60. PubMed ID: 18568103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.
    Wiker C; Linnér L; Wadenberg ML; Svensson TH
    Neuropsychiatr Dis Treat; 2005 Dec; 1(4):356-72. PubMed ID: 18568117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.
    Wiker C; Schilström B; Sandbäck C; Wadenberg ML; Svensson TH
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):845-50. PubMed ID: 18405415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.
    Hertel P; Nomikos GG; Iurlo M; Svensson TH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):74-86. PubMed ID: 8935802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.
    Wadenberg ML; Hertel P; Fernholm R; Hygge Blakeman K; Ahlenius S; Svensson TH
    J Neural Transm (Vienna); 2000; 107(10):1229-38. PubMed ID: 11129112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.
    Frånberg O; Wiker C; Marcus MM; Konradsson A; Jardemark K; Schilström B; Shahid M; Wong EH; Svensson TH
    Psychopharmacology (Berl); 2008 Feb; 196(3):417-29. PubMed ID: 17940749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.
    Marcus MM; Jardemark K; Malmerfelt A; Gertow J; Konradsson-Geuken A; Svensson TH
    Synapse; 2012 Apr; 66(4):277-90. PubMed ID: 22121030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
    Marcus MM; Wiker C; Frånberg O; Konradsson-Geuken A; Langlois X; Jardemark K; Svensson TH
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):891-903. PubMed ID: 19835668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
    Wadenberg MG; Browning JL; Young KA; Hicks PB
    Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
    Hertel P; Fagerquist MV; Svensson TH
    Science; 1999 Oct; 286(5437):105-7. PubMed ID: 10506554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
    Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.
    Björkholm C; Jardemark K; Marcus MM; Malmerfelt A; Nyberg S; Schilström B; Svensson TH
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):709-20. PubMed ID: 22732518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.
    Wadenberg ML; Kapur S; Soliman A; Jones C; Vaccarino F
    Psychopharmacology (Berl); 2000 Jul; 150(4):422-9. PubMed ID: 10958084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.